Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity

類似資料

• Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust antitumor immunity
  著者:: Redmond, William L., 等
  出版事項: (2013)
• Combination OX40 agonism/CTLA-4 blockade with vaccination reverses anergy and primes tumor-specific CD8 T cells in mice with spontaneous prostate cancer
  著者:: Linch, Stefanie N, 等
  出版事項: (2013)
• Combined OX40 ligation plus CTLA-4 blockade: More than the sum of its parts
  著者:: Linch, Stefanie N, 等
  出版事項: (2014)
• Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T cell anergy and promotes survival in tumor-bearing mice
  著者:: Linch, Stefanie, 等
  出版事項: (2015)
• Combination OX40 agonism/CTLA-4 blockade with HER2 vaccination reverses T-cell anergy and promotes survival in tumor-bearing mice
  著者:: Linch, Stefanie N., 等
  出版事項: (2016)